Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Proteome Sciences plc    PRM   GB0003104196

Delayed Quote. Delayed  - 04/29 05:35:10 pm
20 GBp   -4.76%
04/05 PROTEOME SCIENC : Block Admission Report
04/05 PROTEOME SCIENC : Welcomes Supportive Reports On Protein Profiling
04/05 PROTEOME SCIENC : Deep Protein Profiling Key To Improving Cancer Tre..
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
04/25/2016 04/26/2016 04/27/2016 04/28/2016 04/29/2016 Date
21.5(c) 21(c) 21(c) 21(c) 20(c) Last
134 679 71 090 11 424 74 108 244 448 Volume
+2.38% -2.33% 0.00% 0.00% -4.76% Change
More quotes
Financials ( GBP)
Sales 2015 1,90 M
EBIT 2015 -3,70 M
Net income 2015 -3,70 M
Debt 2015 7,10 M
Yield 2015 -
Sales 2016 3,00 M
EBIT 2016 -3,20 M
Net income 2016 -3,00 M
Debt 2016 9,40 M
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
EV / Sales 2015 27,7x
EV / Sales 2016 18,3x
Capitalization 45,6 M
More Financials
Company
Proteome Sciences Plc engages in applied proteomics and peptidomics services and applications.It offers proprietary technologies for protein and peptide biomarker discovery, validation, and assay development.It focuses on developing proprietary protein biomarkers for neurological diseases,... 
More about the company
Latest news on PROTEOME SCIENCES PLC
04/05 PROTEOME SCIENCES : Block Admission Report
04/05 PROTEOME SCIENCES : Welcomes Supportive Reports On Protein Profiling
04/05 PROTEOME SCIENCES : Deep Protein Profiling Key To Improving Cancer Treatment
02/29 PROTEOME SCIENCES : Starts 2016 Well, Production Capacity Up
02/29 PROTEOME SCIENCES : Trading Update
01/08 PROTEOME SCIENCES : Director Dealing
2015 PROTEOME SCIENCES : Gets Positive Results From CK1d Inhibitors Study
2015 PROTEOME SCIENCES : Block Admission Return
More news
Sector news : Bio Therapeutic Drugs
01:01p REGENERON PHARMACEUTICALS : Announces Positive Topline Results from Phase 2/3 Fa..
01:01p QUINTILES TRANSNATIONAL : Novogen Provides Update On Development Of Cantrixil
05/01 BRIEF : Sanofi girds for another fight
More sector news : Bio Therapeutic Drugs


Comments 
Advertisement
Chart PROTEOME SCIENCES PLC
Duration : Period :
Proteome Sciences plc Technical Analysis Chart | PRM | GB0003104196 | 4-Traders
Full-screen chart
Technical analysis trends PROTEOME SCIENCES...
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials